Average Co-Inventor Count = 5.59
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (29 from 1,536 patents)
2. Centrexion Therapeutics Corporation (5 from 36 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (4 from 194 patents)
4. Hydra Biosciences, Inc. (3 from 49 patents)
5. Arena Pharmaceuticals, Inc. (2 from 216 patents)
38 patents:
1. 12421218 - Substituted pyrazine-carboxamide derivatives
2. 12291532 - Substituted xanthines as modulators of TRPC5 activity
3. 12209094 - CCR2 receptor antagonists and uses thereof
4. 12115157 - 3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as medicament
5. 12071403 - Modulators of complex I
6. 11795147 - Modulators of complex I
7. 11780827 - Substituted 3-phenoxyazetidin-1-yl-pyrazines
8. 11731981 - CCR2 receptor antagonists and uses thereof
9. 11339161 - Triazolo pyridines as modulators of gamma-secretase
10. 11198696 - Substituted xanthines as inhibitors of transient receptor potential cation channel subfamily c, member 5 activity
11. 11046706 - CCR2 receptor antagonists and uses thereof
12. 10329292 - Substituted xanthine derivatives
13. 10196402 - CCR2 receptor antagonists and uses thereof
14. 9676781 - Substituted glycinamides, process for their manufacture and use thereof as medicaments
15. 9670222 - CCR2 receptor antagonists and uses thereof